How do we initialize cross-border partnerships between pharma, biobanking and healthcare? What roles will clinics and health organizations, academy and industry have in making this a reality? An inventory is needed to create a shared vision of how a triple-helix approach can be developed, leading to innovative processes and personalized solutions. How can we get a closer collaboration between Swedish & Danish Life Science? How can the Nordic Region reach its full potential to become a European first-class innovation example using a world class research infrastructure and outstanding talents?
New for this fifth edition of the event is that partnering meetings will be facilitated by our one-to-one meeting partnering software available for all delegates at The Future of Swedish & Danish Life Science. We charge no entry fee and will provide lunch and refreshments. The day will be covered by the press.
